MW 474.7 Da, Purity >98%. Endogenous glucosylceramide synthase inhibitor. Ceramide (ab141743, ab141745) structural analog. Blocks karyokinesis and reduces cyst production. Inhibits glucosylceramide synthesis.
149022-18-4
> 98%
474.7 Da
C29H50N2O3
3008318
Synthetic
MW 474.7 Da, Purity >98%. Endogenous glucosylceramide synthase inhibitor. Ceramide (ab141743, ab141745) structural analog. Blocks karyokinesis and reduces cyst production. Inhibits glucosylceramide synthesis.
149022-18-4
> 98%
474.7 Da
C29H50N2O3
3008318
Synthetic
(1R,2R)-1-phenyl-2-palmitoylamino-3-morpholino-1-propanol
Endogenous glucosylceramide synthase inhibitor. Ceramide (ab141743, ab141745) structural analog. Blocks karyokinesis and reduces cyst production. Inhibits glucosylceramide synthesis.
CCCCCCCCCCCCCCCC(=O)NC(CN1CCOCC1)C(C2=CC=CC=C2)O
CCCCCCCCCCCCCCCC(=O)N[C@H](CN1CCOCC1)[C@@H](C2=CC=CC=C2)O
InChI=1S/C29H50N2O3/c1-2-3-4-5-6-7-8-9-10-11-12-13-17-20-28(32)30-27(25-31-21-23-34-24-22-31)29(33)26-18-15-14-16-19-26/h14-16,18-19,27,29,33H,2-13,17,20-25H2,1H3,(H,30,32)/t27-,29-/m1/s1
OFBANDBMHLEMFA-XRKRLSELSA-N
N-[(1R,2R)-1-hydroxy-3-morpholin-4-yl-1-phenylpropan-2-yl]hexadecanamide
Ambient - Can Ship with Ice
-20°C
Store under desiccating conditions, The product can be stored for up to 12 months
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
2D chemical structure image of ab144023, D,L-threo-PPMP, Glucosylceramide synthase inhibitor
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com